All
  • All
  • Researchers and Clinicians
Oct 10 @ 5:26 pm

Antibodies

Information on where to find commercially produced antibodies.

more
Oct 10 @ 5:26 pm

ATTeST

This trial assessed the safety and efficacy of the EryDex System to treat neurological symptoms associated with A-T.

more
Oct 10 @ 5:26 pm

Automated Gait Analysis

Tools to measure the neurological problems in mice with ataxia-telangiectasia (A-T)

more
Oct 10 @ 5:26 pm

Baclofen Study

At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.

more
Oct 10 @ 5:26 pm

Betamethasone Trials

These trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.

more
Oct 10 @ 5:26 pm

Brain and Tissue Bank

A-T brain tissue and other tissues may be available for research purposes.

more
Oct 10 @ 5:26 pm

Cell Bank

The A-TCP has established a program for the collection, submission and maintenance of cell lines from patients with A-T.

more
Oct 10 @ 5:26 pm

Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.

more
Oct 10 @ 5:26 pm

Dexamethasone Trial

This open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.

more
Oct 10 @ 5:26 pm

Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.

more
Oct 10 @ 5:26 pm

Global A-T Family Data Platform

The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.

more
Oct 10 @ 5:26 pm

IB1001 TRIAL

IntraBio, Inc. is studying the effects of N-Acetyl-L-Leucine on A-T.

more